Murchinson’s Pfizer PFE Stock Holding History

Murchinson’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,000	Closed	-$40K	–	126
2021 Q4	$40K	Buy	+12,000	New	+$595K	﹤0.01%	124

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Murchinson's PFE Position: Q1 2022 in Review

Murchinson sold out of Pfizer (PFE) in Q1 2022, closing a stake of 1,200,000 shares — an estimated $70.9M sold.

Murchinson first reported a position in PFE in Q4 2021 and held it in 1 quarter. The position peaked at $70.9M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

Murchinson reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
Murchinson sold 1,200,000 Pfizer shares in Q1 2022, an estimated $70.9M.
Murchinson first reported a position in Pfizer in Q4 2021 and held it in 1 quarter.
Murchinson's Pfizer position peaked at $70.9M in Q4 2021.
3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Murchinson's 13F filing for Q1 2022, filed 12 May 2022.